The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein

Atherosclerosis

Volumn 225, Issue 2, 2012, Pages 397-402

  Dalmeijer, G W ^a   van der Schouw, Y T ^a   Magdeleyns, E ^b   Ahmed, N ^b   Vermeer, C ^b   Beulens, J W J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Matrix gla protein; Menaquinone; MGP; Supplementation; Vitamin k

Indexed keywords

MENAQUINONE; MENAQUINONE 7; OSTEOCALCIN; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARBOXYLATION; CARDIOVASCULAR RISK; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION;

ADULT; AGED; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; CARBOXYLIC ACIDS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NETHERLANDS; OSTEOCALCIN; PHOSPHORYLATION; TIME FACTORS; VITAMIN K 2; VITAMINS;

EID: 84869499148     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.09.019     Document Type: Article

References (31)

1. Booth S.L., Suttie J.W. Dietary intake and adequacy of vitamin K. J Nutr 1998, 128:785-788.
2. Shearer M.J., Bach A., Kohlmeier M. Chemistry, nutritional sources, tissue distribution and metabolism of vitamin K with special reference to bone health. J Nutr 1996, 126:1181S-1186S.
3. Schurgers L.J., Geleijnse J.M., Grobbee D.E., et al. Nutritional phylloquinone and menaquinone intake in the Netherlands. J Nutr Environ Med 1999, 9:115-122.
4. Furie B., Bouchard B.A., Furie B.C. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 1999, 93:1798-1808.
5. Shanahan C.M., Proudfoot D., Farzaneh-Far A., Weissberg P.L. The role of Gla proteins in vascular calcification. Crit Rev Eukaryot Gene Expr 1998, 8:357-375.
6. Greenland P., Bonow R.O., Brundage B.H., et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American college of cardiology foundation clinical expert consensus task force (ACCF/AHA writing committee to update the 2000 expert consensus document on electron beam computed tomography) developed in collaboration with the society of atherosclerosis Imaging and prevention and the society of cardiovascular computed tomography. J Am Coll Cardiol 2007, 49:378-402.
7. Luo G., Ducy P., McKee M.D., et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix Gla protein. Nature 1997, 386:78-81.
8. Geleijnse J.M., Vermeer C., Grobbee D.E., et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 2004, 134:3100-3105.
9. Gast G.C., de Roos N.M., Sluijs I., et al. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis 2009, 19:504-510.
10. Beulens J.W., Bots M.L., Atsma F., et al. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis 2009, 203:489-493.
11. Shea M.K., O'Donnell C.J., Hoffmann U., et al. Vitamin K supplementation and progression of coronary artery calcium in older men and women. Am J Clin Nutr 2009, 89:1799-1807.
12. Cranenburg E.C., Koos R., Schurgers L.J., et al. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost 2010, 104.
13. Rennenberg R.J., de Leeuw P.W., Kessels A.G., et al. Calcium scores and matrix Gla protein levels: association with vitamin K status. Eur J Clin Invest 2010, 40:344-349.
14. Shea M.K., O'Donnell C.J., Vermeer C., et al. Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults. J Nutr 2011, 141:1529-1534.
15. Westenfeld R., Krueger T., Schlieper G., et al. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis 2012, 59:186-195.
16. Theuwissen E., Cranenburg E.C., Knapen M.H., et al. Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects. Br J Nutr 2012, 1-6.
17. Kamao M., Suhara Y., Tsugawa N., et al. Vitamin K content of foods and dietary vitamin K intake in Japanese young women. J Nutr Sci Vitaminol (Tokyo) 2007, 53:464-470.
18. Schurgers L.J., Teunissen K.J., Hamulyak K., Knapen M.H., Vik H., Vermeer C. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 2007, 109:3279-3283.
19. AnonymousNederlands Voedingsstoffenbestand Den Haag: Voorlichtingsbureau voor de Voeding 1996.
20. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
21. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
22. Schurgers L.J., Cranenburg E.C., Vermeer C. Matrix Gla-protein: the calcification inhibitor in need of vitamin K. Thromb Haemost 2008, 100:593-603.
23. Dalmeijer GW, Schouw van der YT, Vermeer C, Magdeleyns E, Schurgers LJ, Beulens JW. Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women. J Nutr Biochem, in press.
24. Cranenburg E.C., Brandenburg V.M., Vermeer C., et al. Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patients. Thromb Haemost 2009, 101:359-366.
25. Schlieper G., Westenfeld R., Kruger T., et al. Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. J Am Soc Nephrol 2011, 22:387-395.
26. Nagasawa Y., Fujii M., Kajimoto Y., Imai E., Hori M. Vitamin K2 and serum cholesterol in patients on continuous ambulatory peritoneal dialysis. Lancet 1998, 351:724.
27. Beulens J.W., van der A.D., Grobbee D.E., Sluijs I., Spijkerman A.M., van der Schouw Y.T. Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes. Diabetes Care 2010, 33:1699-1705.
28. Sakamoto N., Nishiike T., Iguchi H., Sakamoto K. Possible effects of one week vitamin K (menaquinone-4) tablets intake on glucose tolerance in healthy young male volunteers with different descarboxy prothrombin levels. Clin Nutr 2000, 19:259-263.
29. Yoshida M., Booth S.L., Meigs J.B., Saltzman E., Jacques P.F. Phylloquinone intake, insulin sensitivity, and glycemic status in men and women. Am J Clin Nutr 2008, 88:210-215.
30. Yoshida M., Jacques P.F., Meigs J.B., et al. Effect of vitamin K supplementation on insulin resistance in older men and women. Diabetes Care 2008, 31:2092-2096.
31. Schurgers L.J., Vermeer C. Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis 2000, 30:298-307.